Teladoc director granted 30,441 RSUs

Fenwick Sandra L reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

Fenwick Sandra L reported acquisition or exercise transactions in this Form 4 filing.

Teladoc Health, Inc. director Sandra L. Fenwick received a grant of 30,441 restricted stock units, each representing one share of Teladoc common stock. These RSUs vest in full on the earlier of May 21, 2027 or the day immediately before Teladoc’s 2027 annual stockholder meeting.

Vested shares will be delivered to Fenwick on the earliest of several events: within a set period after her separation of service, around a qualifying Change of Control as defined in Teladoc’s Deferred Compensation Plan for Non-Employee Directors, or upon her death.

Insider Trade Summary

Grant/Award: 30,441 shares

Grant/Award 1 txn

Insider Fenwick Sandra L

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Restricted Stock Units	30,441	$0.00	$0.00

Holdings After Transaction: Restricted Stock Units — 30,441 contracts (Direct)

Footnotes (2)

1. F1. Each restricted stock unit represents a contingent right to receive one share of TDOC common stock.
2. F2. The restricted stock units vest in full on the earlier of (i) May 21, 2027 and (ii) the day immediately preceding the issuer's 2027 annual meeting of stockholders. Vested shares will be delivered to the reporting person on the earliest to occur of (i) within 90 days following the date that is 30 days following the reporting person's separation of service, (ii) immediately prior to, on or within 30 days following a Change of Control (as defined in the issuer's Deferred Compensation Plan for Non-Employee Directors) and (iii) the reporting person's death.

Key Figures

RSUs granted: 30,441 units Underlying shares: 30,441 shares Grant price: $0.0000 per unit +1 more

4 metrics

RSUs granted 30,441 units Restricted stock units awarded to Sandra L. Fenwick

Underlying shares 30,441 shares Common shares underlying the RSU grant

Grant price $0.0000 per unit Equity award with no cash price paid by director

Vesting date Earlier of May 21, 2027 or day before 2027 meeting Single full vesting trigger for RSU award

Key Terms

Restricted Stock Units, Change of Control, Deferred Compensation Plan for Non-Employee Directors

3 terms

Restricted Stock Units financial

"Each restricted stock unit represents a contingent right to receive one share of TDOC common stock."

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

Change of Control financial

"immediately prior to, on or within 30 days following a Change of Control"

A change of control occurs when the ownership or management of a company shifts significantly, such as through a sale, merger, or acquisition, resulting in new leadership or ownership structure. This change can impact the company's direction and decision-making, which is important for investors because it may affect the company's stability, strategy, and future prospects.

Deferred Compensation Plan for Non-Employee Directors financial

"Change of Control (as defined in the issuer's Deferred Compensation Plan for Non-Employee Directors)"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Teladoc (TDOC) director Sandra Fenwick report in this Form 4?

Sandra L. Fenwick reported receiving 30,441 restricted stock units, each convertible into one share of Teladoc common stock. This is a compensation-related equity award, not an open-market purchase or sale of shares, and reflects additional stock-based pay for her board service.

How many Teladoc (TDOC) restricted stock units were granted to Sandra Fenwick?

The filing shows a grant of 30,441 restricted stock units to Sandra L. Fenwick. Each unit represents a contingent right to receive one share of Teladoc common stock, providing equity-based compensation tied directly to the company’s share price performance over time.

When do Sandra Fenwick’s Teladoc (TDOC) restricted stock units vest?

The restricted stock units vest in full on the earlier of May 21, 2027 or the day immediately preceding Teladoc’s 2027 annual stockholder meeting. This single vesting date structure aligns the director’s compensation with a multi-year service and governance period.

When will Sandra Fenwick receive the Teladoc (TDOC) shares from her RSUs?

Vested shares are delivered on the earliest of three events: after a defined period following her separation of service, around a qualifying Change of Control under the Deferred Compensation Plan, or upon her death. This deferral framework structures timing of actual share delivery.

Is this Teladoc (TDOC) Form 4 a stock purchase or sale by Sandra Fenwick?

The Form 4 reflects an equity award, not a market trade. Sandra L. Fenwick acquired 30,441 restricted stock units as a grant, with no price paid per unit, rather than buying or selling Teladoc shares on the open market or through a discretionary transaction.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/21/2026 - 05:13 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Fenwick Sandra L

(Last) (First) (Middle)

C/O TELADOC HEALTH, INC.

155 E 44TH ST, FLOOR 17

(Street)

NEW YORK NEW YORK 10017

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Teladoc Health, Inc. [ TDOC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/21/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	(1)	05/21/2026		A		30,441		(2)	(2)	Common Stock	30,441	$0	30,441	D

Explanation of Responses:

1. Each restricted stock unit represents a contingent right to receive one share of TDOC common stock.

2. The restricted stock units vest in full on the earlier of (i) May 21, 2027 and (ii) the day immediately preceding the issuer's 2027 annual meeting of stockholders. Vested shares will be delivered to the reporting person on the earliest to occur of (i) within 90 days following the date that is 30 days following the reporting person's separation of service, (ii) immediately prior to, on or within 30 days following a Change of Control (as defined in the issuer's Deferred Compensation Plan for Non-Employee Directors) and (iii) the reporting person's death.

Remarks:

	/s/ Adam C. Vandervoort, Attorney-in-Fact	05/21/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)